Open Access

B‑cell lymphoma 2 is associated with advanced tumor grade and clinical stage, and reduced overall survival in young Chinese patients with colorectal carcinoma

  • Authors:
    • Jiasheng Wang
    • Gan He
    • Qiang Yang
    • Lian Bai
    • Bin Jian
    • Qugang Li
    • Zhongfu Li
  • View Affiliations

  • Published online on: April 13, 2018     https://doi.org/10.3892/ol.2018.8489
  • Pages: 9009-9016
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The development of biomarkers that accurately and reliably detect colorectal cancer is a promising approach for colorectal cancer screening. Therefore, the objective of the present study was to evaluate the protein expression of α‑methylacyl‑CoA racemase (P504S/AMACR), tumor protein p53 (p53), B‑cell lymphoma 2 (Bcl‑2) and Ki‑67/mindbomb E3 ubiquitin protein ligase 1 (MIB‑1) in a population of Chinese patients with colorectal carcinoma. Colorectal tumors with matched normal tissue margins were collected from 148 surgical patients, and the demographic and clinical characteristics were collected. Immunohistochemical staining and western blot analysis of P504S/AMACR, p53, Bcl‑2 and Ki‑67/MIB‑1 were conducted. Statistical analyses were used to compare protein expression in the colorectal tumors and matched normal tissue margins and to identify any associations between them and various clinicopathological parameters. Survival analyses were performed using the Kaplan‑Meier method. In the present study, immunohistochemistry and western blot analysis revealed significantly higher expression of all four proteins in colorectal tumors compared with matched normal tissue margins (P<0.001). Spearman's rank correlation analysis revealed that Bcl‑2 expression was negatively correlated with pathological grade and Tumor‑Node‑Metastasis (TNM) stage (‑0.827 and ‑0.388, respectively; P<0.05). Bcl‑2 expression was revealed to be a significant prognostic indicator of colorectal carcinoma [relative risk (95% CI), 0.703 (0.552‑0.895); P<0.05]. The log‑rank test revealed a significant association between low Bcl‑2 expression and reduced overall survival (P=0.039), as well as a significant association between older age (>55 years) and reduced overall survival (P<0.001) in Chinese patients with colorectal carcinoma. In conclusion, low expression of Bcl‑2 is significantly correlated with advanced pathological grade and TNM stage and is a prognostic indicator of reduced overall survival in young Chinese patients with colorectal carcinoma.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 15 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang J, He G, Yang Q, Bai L, Jian B, Li Q and Li Z: B‑cell lymphoma 2 is associated with advanced tumor grade and clinical stage, and reduced overall survival in young Chinese patients with colorectal carcinoma. Oncol Lett 15: 9009-9016, 2018.
APA
Wang, J., He, G., Yang, Q., Bai, L., Jian, B., Li, Q., & Li, Z. (2018). B‑cell lymphoma 2 is associated with advanced tumor grade and clinical stage, and reduced overall survival in young Chinese patients with colorectal carcinoma. Oncology Letters, 15, 9009-9016. https://doi.org/10.3892/ol.2018.8489
MLA
Wang, J., He, G., Yang, Q., Bai, L., Jian, B., Li, Q., Li, Z."B‑cell lymphoma 2 is associated with advanced tumor grade and clinical stage, and reduced overall survival in young Chinese patients with colorectal carcinoma". Oncology Letters 15.6 (2018): 9009-9016.
Chicago
Wang, J., He, G., Yang, Q., Bai, L., Jian, B., Li, Q., Li, Z."B‑cell lymphoma 2 is associated with advanced tumor grade and clinical stage, and reduced overall survival in young Chinese patients with colorectal carcinoma". Oncology Letters 15, no. 6 (2018): 9009-9016. https://doi.org/10.3892/ol.2018.8489